Skip to main content
Erschienen in: Acta Diabetologica 12/2018

17.09.2018 | Original Article

Heterogeneity of gestational diabetes (GDM) and challenges in developing a GDM risk score

verfasst von: Emilia Huvinen, Johan G. Eriksson, Beata Stach-Lempinen, Aila Tiitinen, Saila B. Koivusalo

Erschienen in: Acta Diabetologica | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims

Gestational diabetes (GDM) affects a growing number of women and identification of individuals at risk, e.g., with risk prediction models, would be important. However, the performance of GDM risk scores has not been optimal. Here, we assess the impact of GDM heterogeneity on the performance of two top-rated GDM risk scores.

Methods

This is a substudy of the RADIEL trial—a lifestyle intervention study including women at high GDM risk. We assessed the GDM risk score by Teede and that developed by Van Leeuwen in our high-risk cohort of 510 women. To investigate the heterogeneity of GDM, we further divided the women according to GDM history, BMI, and parity. With the goal of identifying novel predictors of GDM, we further analyzed 319 women with normal glucose tolerance in the first trimester.

Results

Both risk scores underestimated GDM incidence in our high-risk cohort. Among women with a BMI ≥ 30 kg/m2 and/or previous GDM, 49.4% developed GDM and 37.4% received the diagnosis already in the first trimester. Van Leeuwen score estimated a 19% probability of GDM and Teede succeeded in risk identification in 61%. The lowest performance of the risk scores was seen among the non-obese women. Fasting plasma glucose, HbA1c, and family history of diabetes were predictors of GDM in the total study population. Analysis of subgroups did not provide any further information.

Conclusions

Our findings suggest that the marked heterogeneity of GDM challenges the development of risk scores for detection of GDM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rautio N, Jokelainen J, Korpi-Hyovalti E, Oksa H, Saaristo T, Peltonen M, Moilanen L, Vanhala M, Uusitupa M, Tuomilehto J, Keinanen-Kiukaanniemi S (2014) Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project. J Women’s Health 23(6):506–512. https://doi.org/10.1089/jwh.2013.4520 CrossRef Rautio N, Jokelainen J, Korpi-Hyovalti E, Oksa H, Saaristo T, Peltonen M, Moilanen L, Vanhala M, Uusitupa M, Tuomilehto J, Keinanen-Kiukaanniemi S (2014) Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project. J Women’s Health 23(6):506–512. https://​doi.​org/​10.​1089/​jwh.​2013.​4520 CrossRef
2.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research G (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403CrossRef Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research G (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403CrossRef
3.
Zurück zum Zitat Koivusalo SB, Rono K, Klemetti MM, Roine RP, Lindstrom J, Erkkola M, Kaaja RJ, Poyhonen-Alho M, Tiitinen A, Huvinen E, Andersson S, Laivuori H, Valkama A, Meinila J, Kautiainen H, Eriksson JG, Stach-Lempinen B (2016) Gestational diabetes mellitus can be prevented by lifestyle intervention: the finnish gestational diabetes prevention study (RADIEL) a randomized controlled trial. Diabetes Care 39(1):24–30. https://doi.org/10.2337/dc15-0511 CrossRefPubMed Koivusalo SB, Rono K, Klemetti MM, Roine RP, Lindstrom J, Erkkola M, Kaaja RJ, Poyhonen-Alho M, Tiitinen A, Huvinen E, Andersson S, Laivuori H, Valkama A, Meinila J, Kautiainen H, Eriksson JG, Stach-Lempinen B (2016) Gestational diabetes mellitus can be prevented by lifestyle intervention: the finnish gestational diabetes prevention study (RADIEL) a randomized controlled trial. Diabetes Care 39(1):24–30. https://​doi.​org/​10.​2337/​dc15-0511 CrossRefPubMed
4.
Zurück zum Zitat Paulweber B, Valensi P, Lindstrom J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Huhmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, Barengo N, Barengo R, Boavida JM, Christov V, Claussen B, Cos X, Deceukelier S, Djordjevic P, Fischer M, Gabriel-Sanchez R, Goldfracht M, Gomez JL, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Huttunen J, Karadeniz S, Khalangot M, Kohler D, Kopp V, Kronsbein P, Kyne-Grzebalski D, Lalic N, Landgraf R, McIntosh C, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Peltonen M, Perrenoud L, Pfeiffer A, Polonen A, Raposo F, Reinehr T, Robinson C, Rothe U, Saaristo T, Scholl J, Spiers S, Stemper T, Stratmann B, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Undeutsch A, Valadas C, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T (2010) A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 42(Suppl 1):S3–S36. https://doi.org/10.1055/s-0029-1240928 CrossRefPubMed Paulweber B, Valensi P, Lindstrom J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Huhmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, Barengo N, Barengo R, Boavida JM, Christov V, Claussen B, Cos X, Deceukelier S, Djordjevic P, Fischer M, Gabriel-Sanchez R, Goldfracht M, Gomez JL, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Huttunen J, Karadeniz S, Khalangot M, Kohler D, Kopp V, Kronsbein P, Kyne-Grzebalski D, Lalic N, Landgraf R, McIntosh C, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Peltonen M, Perrenoud L, Pfeiffer A, Polonen A, Raposo F, Reinehr T, Robinson C, Rothe U, Saaristo T, Scholl J, Spiers S, Stemper T, Stratmann B, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Undeutsch A, Valadas C, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T (2010) A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 42(Suppl 1):S3–S36. https://​doi.​org/​10.​1055/​s-0029-1240928 CrossRefPubMed
7.
Zurück zum Zitat Lamain-de Ruiter M, Kwee A, Naaktgeboren CA, de Groot I, Evers IM, Groenendaal F, Hering YR, Huisjes AJM, Kirpestein C, Monincx WM, Siljee JE, Van ‘t Zelfde A, van Oirschot CM, Vankan-Buitelaar SA, Vonk MAAW, Wiegers TA, Zwart JJ, Franx A, Moons KGM, Koster MPH (2016) External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. BMJ 354:4338. https://doi.org/10.1136/bmj.i4338 CrossRef Lamain-de Ruiter M, Kwee A, Naaktgeboren CA, de Groot I, Evers IM, Groenendaal F, Hering YR, Huisjes AJM, Kirpestein C, Monincx WM, Siljee JE, Van ‘t Zelfde A, van Oirschot CM, Vankan-Buitelaar SA, Vonk MAAW, Wiegers TA, Zwart JJ, Franx A, Moons KGM, Koster MPH (2016) External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. BMJ 354:4338. https://​doi.​org/​10.​1136/​bmj.​i4338 CrossRef
9.
Zurück zum Zitat Ahlqvist E, Storm P, Karajamaki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P, Wessman Y, Shaat N, Spegel P, Mulder H, Lindholm E, Melander O, Hansson O, Malmqvist U, Lernmark A, Lahti K, Forsen T, Tuomi T, Rosengren AH, Groop L (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(18)30051-2 CrossRefPubMed Ahlqvist E, Storm P, Karajamaki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P, Wessman Y, Shaat N, Spegel P, Mulder H, Lindholm E, Melander O, Hansson O, Malmqvist U, Lernmark A, Lahti K, Forsen T, Tuomi T, Rosengren AH, Groop L (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. https://​doi.​org/​10.​1016/​S2213-8587(18)30051-2 CrossRefPubMed
10.
Zurück zum Zitat Huvinen E, Grotenfelt NE, Eriksson JG, Rono K, Klemetti MM, Roine R, Poyhonen-Alho M, Tiitinen A, Andersson S, Laivuori H, Knip M, Valkama A, Meinila J, Kautiainen H, Stach-Lempinen B, Koivusalo SB (2016) Heterogeneity of maternal characteristics and impact on gestational diabetes (GDM) risk-Implications for universal GDM screening? Ann Med 48(1–2):52–58. https://doi.org/10.3109/07853890.2015.1131328 CrossRefPubMed Huvinen E, Grotenfelt NE, Eriksson JG, Rono K, Klemetti MM, Roine R, Poyhonen-Alho M, Tiitinen A, Andersson S, Laivuori H, Knip M, Valkama A, Meinila J, Kautiainen H, Stach-Lempinen B, Koivusalo SB (2016) Heterogeneity of maternal characteristics and impact on gestational diabetes (GDM) risk-Implications for universal GDM screening? Ann Med 48(1–2):52–58. https://​doi.​org/​10.​3109/​07853890.​2015.​1131328 CrossRefPubMed
11.
Zurück zum Zitat Bo S, Menato G, Pinach S, Signorile A, Bardelli C, Lezo A, Marchisio B, Gentile L, Cassader M, Massobrio M, Pagano G (2003) Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens. Diabet Med 20(1):64–68CrossRef Bo S, Menato G, Pinach S, Signorile A, Bardelli C, Lezo A, Marchisio B, Gentile L, Cassader M, Massobrio M, Pagano G (2003) Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens. Diabet Med 20(1):64–68CrossRef
12.
Zurück zum Zitat Damm P, Kuhl C, Hornnes P, Molsted-Pedersen L (1995) A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care 18(5):654–665CrossRef Damm P, Kuhl C, Hornnes P, Molsted-Pedersen L (1995) A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care 18(5):654–665CrossRef
13.
Zurück zum Zitat Freinkel N, Metzger BE, Phelps RL, Dooley SL, Ogata ES, Radvany RM, Belton A (1985) Gestational diabetes mellitus. Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring. Diabetes 34(Suppl 2):1–7CrossRef Freinkel N, Metzger BE, Phelps RL, Dooley SL, Ogata ES, Radvany RM, Belton A (1985) Gestational diabetes mellitus. Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring. Diabetes 34(Suppl 2):1–7CrossRef
15.
19.
Zurück zum Zitat Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ, Group HSCR (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35(4):780–786. https://doi.org/10.2337/dc11-1790 CrossRefPubMedPubMedCentral Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ, Group HSCR (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35(4):780–786. https://​doi.​org/​10.​2337/​dc11-1790 CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat (2014) Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract 103(3):341–363 (2014) Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract 103(3):341–363
21.
Zurück zum Zitat Benhalima K, Mathieu C, Damm P, Van Assche A, Devlieger R, Desoye G, Corcoy R, Mahmood T, Nizard J, Savona-Ventura C, Dunne F (2015) A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 58(7):1422–1429. https://doi.org/10.1007/s00125-015-3615-7 CrossRefPubMed Benhalima K, Mathieu C, Damm P, Van Assche A, Devlieger R, Desoye G, Corcoy R, Mahmood T, Nizard J, Savona-Ventura C, Dunne F (2015) A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 58(7):1422–1429. https://​doi.​org/​10.​1007/​s00125-015-3615-7 CrossRefPubMed
22.
Zurück zum Zitat Weinert LS (2010) International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Diabetes Care 33(7):e97. https://doi.org/10.2337/dc10-0544 CrossRefPubMed Weinert LS (2010) International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Diabetes Care 33(7):e97. https://​doi.​org/​10.​2337/​dc10-0544 CrossRefPubMed
24.
Zurück zum Zitat Mane L, Flores-Le Roux JA, Benaiges D, Rodriguez M, Marcelo I, Chillaron JJ, Pedro-Botet J, Llaurado G, Gortazar L, Carreras R, Paya A (2016) Role of first trimester HbA1c as a predictor of adverse obstetric outcomes in a multi-ethnic cohort. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2016-2581 CrossRef Mane L, Flores-Le Roux JA, Benaiges D, Rodriguez M, Marcelo I, Chillaron JJ, Pedro-Botet J, Llaurado G, Gortazar L, Carreras R, Paya A (2016) Role of first trimester HbA1c as a predictor of adverse obstetric outcomes in a multi-ethnic cohort. J Clin Endocrinol Metab. https://​doi.​org/​10.​1210/​jc.​2016-2581 CrossRef
29.
Zurück zum Zitat White SL, Lawlor DA, Briley AL, Godfrey KM, Nelson SM, Oteng-Ntim E, Robson SC, Sattar N, Seed PT, Vieira MC, Welsh P, Whitworth M, Poston L, Pasupathy D, Consortium U (2016) Early antenatal prediction of gestational diabetes in obese women: development of prediction tools for targeted intervention. PLoS One [Electron Resour] 11(12):e0167846. https://doi.org/10.1371/journal.pone.0167846 CrossRef White SL, Lawlor DA, Briley AL, Godfrey KM, Nelson SM, Oteng-Ntim E, Robson SC, Sattar N, Seed PT, Vieira MC, Welsh P, Whitworth M, Poston L, Pasupathy D, Consortium U (2016) Early antenatal prediction of gestational diabetes in obese women: development of prediction tools for targeted intervention. PLoS One [Electron Resour] 11(12):e0167846. https://​doi.​org/​10.​1371/​journal.​pone.​0167846 CrossRef
30.
Zurück zum Zitat American Diabetes A (2017) 8. Pharmacologic approaches to glycemic treatment. Diabetes Care 40(Suppl 1):S64–S74. (doi:40/Supplement_1/S64 [pii]) CrossRef American Diabetes A (2017) 8. Pharmacologic approaches to glycemic treatment. Diabetes Care 40(Suppl 1):S64–S74. (doi:40/Supplement_1/S64 [pii]) CrossRef
Metadaten
Titel
Heterogeneity of gestational diabetes (GDM) and challenges in developing a GDM risk score
verfasst von
Emilia Huvinen
Johan G. Eriksson
Beata Stach-Lempinen
Aila Tiitinen
Saila B. Koivusalo
Publikationsdatum
17.09.2018
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 12/2018
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1224-x

Weitere Artikel der Ausgabe 12/2018

Acta Diabetologica 12/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.